Literature DB >> 1700101

Rubeosis capsulare.

D E Eifrig1, V Hermsen, P McManus, R Cunningham.   

Abstract

Two patients with diabetes had extracapsular cataract extraction with intraocular lens (IOL) implantation. Both developed rubeosis iridis and neovascularization within the lens capsule supporting the IOL, a condition we have termed rubeosis capsular. Argon laser treatment was ineffective in both patients. One patient was successfully treated by virectomy with endophotocoagulation. The other patient had a vitrectomy which was followed by a fibrinoid reaction, continued inflammation, rubeosis, and phthisis bulbi.

Entities:  

Mesh:

Year:  1990        PMID: 1700101     DOI: 10.1016/s0886-3350(13)80783-3

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  5 in total

1.  Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis.

Authors:  Felicia Tai; Efrem D Mandelcorn; Sohel Somani
Journal:  Am J Ophthalmol Case Rep       Date:  2020-10-03

2.  Intravitreal bevacizumab for posterior capsule neovascularization.

Authors:  Mansour Al-Mohaimeed; Saeed Al-Gehedan; Hassan Al Dhibi
Journal:  Saudi J Ophthalmol       Date:  2010-04-02

3.  Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy.

Authors:  Grimelda Yuriana Sánchez-Castro; Alejandra Hitos-Fájer; Erick Mendoza-Schuster; Raul Velez-Montoya; Cecilio Francisco Velasco-Barona
Journal:  Clin Ophthalmol       Date:  2008-09

4.  The options to minimize the surgical trauma to treat ocular diabetic complications and to improve postoperative recovery and quality of life require an individualized approach.

Authors:  Wolfgang F Schrader; Tatjana Josifova
Journal:  EPMA J       Date:  2010-03-16       Impact factor: 6.543

5.  Endocapsular hematoma: a rare form of ocular hemorrhage after thrombolysis with streptokinase.

Authors:  Bodhraj Dhawan; Rhibhu Soni; Rajbir Singh; Vipan Vig
Journal:  N Am J Med Sci       Date:  2014-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.